Randeep Sangha Selected Research

Neutropenia

6/2015

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randeep Sangha Research Topics

Disease

15	Neoplasms (Cancer) 07/2022 - 10/2004
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020 - 08/2007
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2015
4	Exanthema (Rash) 01/2022 - 08/2011
3	Lung Neoplasms (Lung Cancer) 04/2021 - 09/2009
3	Febrile Neutropenia 01/2017 - 12/2011
2	Fatigue 10/2019 - 12/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 06/2015
2	Adenocarcinoma 01/2015 - 10/2004
2	Diarrhea 12/2014 - 12/2011
2	Neoplasm Metastasis (Metastasis) 01/2010 - 09/2009
1	Disease Progression 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Death (Near-Death Experience) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	follicular Thyroid cancer 09/2019
1	Thyroid Neoplasms (Thyroid Cancer) 09/2019
1	Follicular Adenocarcinoma 09/2019
1	Cachexia 04/2019
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2015
1	Neutropenia 06/2015
1	Gastroesophageal Reflux (GERD) 01/2015
1	Stomatitis 12/2014
1	Infections 12/2011
1	Mucositis 12/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 10/2017 - 06/2015
3	Tyrosine Kinase InhibitorsIBA 09/2019 - 12/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 12/2011 - 03/2009
2	NivolumabIBA 01/2022 - 01/2019
2	Pemetrexed (MTA)FDA Link 01/2022 - 12/2014
2	IpilimumabIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2014
2	Carboplatin (JM8)FDA LinkGeneric 10/2019 - 04/2019
2	Gemcitabine FDA Link 01/2017 - 10/2004
2	Docetaxel (Taxotere)FDA Link 12/2011 - 12/2009
2	L-BLP25IBA 11/2007 - 08/2007
2	Glycoproteins (Glycoprotein)IBA 11/2007 - 08/2007
2	Protein Subunit VaccinesIBA 11/2007 - 08/2007
1	Prescription DrugsIBA 07/2022
1	CrizotinibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2021
1	Anaplastic Lymphoma KinaseIBA 09/2020
1	lorlatinibIBA 09/2020
1	enfortumab vedotinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 09/2019
1	IodineIBA 09/2019
1	regorafenibIBA 09/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2019
1	Sorafenib (BAY 43-9006)FDA Link 09/2019
1	lenvatinibIBA 09/2019
1	atezolizumabIBA 07/2019
1	obinutuzumabIBA 10/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Inotuzumab OzogamicinIBA 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	polatuzumab vedotinIBA 06/2015
1	Immunoconjugates (Immunoconjugate)IBA 06/2015
1	AfatinibIBA 12/2014
1	Cetuximab (Erbitux)FDA Link 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2009
1	PlatinumIBA 03/2009
1	Growth Factor ReceptorsIBA 03/2009
1	Monoclonal AntibodiesIBA 03/2009
1	AntigensIBA 11/2007
1	Cancer VaccinesIBA 11/2007
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 10/2004
1	Equilibrative Nucleoside Transporter 1IBA 10/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 08/2007
11	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
1	Transplantation 01/2022
1	Radiotherapy 06/2017
1	Adjuvant Chemotherapy 01/2010
1	Chemoradiotherapy 08/2007